Skip to main content

Table 2 Initial antibiotic agents in all patients with community-acquired pneumonia

From: Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort

 

n = 1834

Monotherapy

Combination therapy

n = 1248

n = 586

Macrolidesa

FQNb

TC

LCM

n = 377

n = 119

n = 82

n = 8

Penicillins

933

199

47

61

2

Cephalosporins

223

163

23

19

6

Carbapenems

25

7

41

2

0

Fluoroquinolones

49

8

―

0

0

Macrolides

12

―

8

0

0

Tetracycline

3

0

0

―

0

Lincomycin

1

0

0

0

―

Oseltamivir

2

0

0

0

0

  1. Abbreviations: FQN fluoroquinolone, TC tetracycline, LCM lincomycin
  2. aOral azithromycin (500 mg/day) for 3 days in 182, oral azithromycin (2 g/day) single dose in 159, azithromycin (500 mg/day) injection in 32, oral erythromycin in 1, and oral clarithromycin in 3 patients
  3. bCiprofloxacin in 4, tosufloxacin in 1, pazufloxacin in 87, and levofloxacin in 27 patients